[
    [
        {
            "time": "2023-10-16",
            "original_text": "2500亿医药白马跌停！CRO板块集体大跌，机构抱团再松动？发生了什么 连续下跌",
            "features": {
                "keywords": [
                    "医药",
                    "白马",
                    "CRO",
                    "板块",
                    "大跌",
                    "机构抱团",
                    "连续下跌"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "CRO"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "2500亿医药白马跌停！CRO板块集体大跌，机构抱团再松动？发生了什么 连续下跌",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-16",
            "original_text": "【观察】潮流还是价值积累？方达控股能否周期与成长共舞？",
            "features": {
                "keywords": [
                    "观察",
                    "价值积累",
                    "方达控股",
                    "周期",
                    "成长"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【观察】潮流还是价值积累？方达控股能否周期与成长共舞？",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-16",
            "original_text": "高瓴资本概念股凯莱英、泰格医药双双放量下挫",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "凯莱英",
                    "泰格医药",
                    "放量下挫"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "CRO"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "高瓴资本概念股凯莱英、泰格医药双双放量下挫",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-16",
            "original_text": "CRO概念随A股集体回调 药明康德下跌9%泰格医药跌超5%",
            "features": {
                "keywords": [
                    "CRO",
                    "A股",
                    "回调",
                    "药明康德",
                    "泰格医药"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "CRO"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "CRO概念随A股集体回调 药明康德下跌9%泰格医药跌超5%",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-16",
            "original_text": "集采后仿制药利润大幅割肉 CRO企业是否会成为创新药时代新风口？",
            "features": {
                "keywords": [
                    "集采",
                    "仿制药",
                    "利润",
                    "CRO",
                    "创新药",
                    "风口"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CRO"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "集采后仿制药利润大幅割肉 CRO企业是否会成为创新药时代新风口？",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-16",
            "original_text": "港股异动︱CRO概念随A股集体回调 药明康德(02359)下挫9% 泰格医药(03347)跌超5% 连续下跌",
            "features": {
                "keywords": [
                    "港股",
                    "CRO",
                    "A股",
                    "回调",
                    "药明康德",
                    "泰格医药",
                    "连续下跌"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "CRO"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "港股异动︱CRO概念随A股集体回调 药明康德(02359)下挫9% 泰格医药(03347)跌超5% 连续下跌",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-16",
            "original_text": "【医药】Moderna再发新冠疫苗积极临床结果，医药进入配置阶段——医药行业周报——中性",
            "features": {
                "keywords": [
                    "医药",
                    "Moderna",
                    "新冠疫苗",
                    "临床结果",
                    "配置阶段"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【医药】Moderna再发新冠疫苗积极临床结果，医药进入配置阶段——医药行业周报——中性",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]